Correlation Between Acutus Medical and NAYA Biosciences,
Can any of the company-specific risk be diversified away by investing in both Acutus Medical and NAYA Biosciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acutus Medical and NAYA Biosciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acutus Medical and NAYA Biosciences,, you can compare the effects of market volatilities on Acutus Medical and NAYA Biosciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acutus Medical with a short position of NAYA Biosciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acutus Medical and NAYA Biosciences,.
Diversification Opportunities for Acutus Medical and NAYA Biosciences,
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Acutus and NAYA is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Acutus Medical and NAYA Biosciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NAYA Biosciences, and Acutus Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acutus Medical are associated (or correlated) with NAYA Biosciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NAYA Biosciences, has no effect on the direction of Acutus Medical i.e., Acutus Medical and NAYA Biosciences, go up and down completely randomly.
Pair Corralation between Acutus Medical and NAYA Biosciences,
If you would invest 80.00 in NAYA Biosciences, on September 2, 2024 and sell it today you would earn a total of 18.00 from holding NAYA Biosciences, or generate 22.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 4.76% |
Values | Daily Returns |
Acutus Medical vs. NAYA Biosciences,
Performance |
Timeline |
Acutus Medical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
NAYA Biosciences, |
Acutus Medical and NAYA Biosciences, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acutus Medical and NAYA Biosciences,
The main advantage of trading using opposite Acutus Medical and NAYA Biosciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acutus Medical position performs unexpectedly, NAYA Biosciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NAYA Biosciences, will offset losses from the drop in NAYA Biosciences,'s long position.Acutus Medical vs. STRATA Skin Sciences | Acutus Medical vs. Axogen Inc | Acutus Medical vs. Ainos Inc | Acutus Medical vs. LENSAR Inc |
NAYA Biosciences, vs. Pekin Life Insurance | NAYA Biosciences, vs. NETGEAR | NAYA Biosciences, vs. Evertz Technologies Limited | NAYA Biosciences, vs. Arrow Electronics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |